Moszkowski Neal's Form 4 filing
R1 RCM Inc.RCM · filed Sep 13, 2022
- Accession no.
- 0001104659-22-099502
- Filed
- Sep 13, 2022, 9:19 AM ET
- Trade date
- Sep 13, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $306.4M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Moszkowski NealCIK 0001041197 | Director, 10% Owner |
| Sousou RamezCIK 0001270155 | Director, 10% Owner |
| TowerBrook Investors, Ltd.CIK 0001599448 | Director, 10% Owner |
| TI IV ACHI Holdings, LPCIK 0001662925 | Director, 10% Owner |
| Ascension Health AllianceCIK 0001663043 | Director, 10% Owner |
| TI IV ACHI Holdings GP, LLCCIK 0001663106 | Director, 10% Owner |
| TCP-Asc GP, LLCCIK 0001663107 | Director, 10% Owner |
| TCP-ASC ACHI Series LLLPCIK 0001663108 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2022 | Common Stock | SSaleDisposed | −15,000,000 | $20.43 | −$306,375,000 | 164,754,055 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Persons may be deemed to be directors by deputization by virtue of their contractual right to appoint directors to the board of directors of the Issuer. As a result, the "Director" box is marked in Item 5 of this Form 4.